Viral Capsid Engineer

17 February 2020

Get in touch!


For more information please contact Prof. Henckaerts: or Dr. Veronick Benoy, tel.: +32 16 32 04 33, mail:

You can apply for this job no later than March 16, 2020 via the online application tool

KU Leuven seeks to foster an environment where all talents can flourish, regardless of gender, age, cultural background, nationality or impairments. If you have any questions relating to accessibility or support, please contact us at

Apply before 16 March 2020

The Laboratory of Viral Cell Biology and Therapeutics (LVCBT) at KU Leuven is recruiting a highly motivated and skilled researcher to fulfill the role of Viral Capsid Engineer.

This vacancy is in the context of the establishment of a clinical program geared towards the treatment of neurodegenerative diseases using AAV vectors. This program will be performed in close collaboration with a biotech company and provides a unique opportunity to contribute to the development of an exciting therapeutic modality.

The position is available immediately

  • You are part of a drug development team in a stimulating setting
  • You are responsible for the development of the next-generation AAV vectors
  • You assess the performance of these vectors in various in vitro and in vivo models
  • You are responsible for reporting on the development process
  • You discuss progress of the research with the supervisor and with the industrial stakeholders
  • You have a Ph.D. in Biomedical Sciences, Bio-engineering, or equivalent
  • You have background knowledge in molecular virology and structural biology
  • You have hands-on experience with a variety of molecular biology research tools
  • Experience in stereotactic injections in rodents is considered an asset
  • You pay attention to details and produce high-quality work
  • You are a team player with strong communication skills
  • You are fluent in English
  • We offer a full-time appointment for one year, with the option to extend
  • A stimulating work environment driven by the ambition to deliver new therapeutics to patients in collaboration with industry
  • Superb career development opportunities with exposure to R&D in an exciting new therapeutic modality; possibility to interact with international collaborators